TNGX EPS Estimates
Tango Therapeutics, Inc.
$22.70
+$0.51(+2.30%)
53
Overall
45
Value
50
Tech
65
Quality
Market Cap
$3.74B
Volume
2.86M
52W Range
$6.69 - $34.39
Target Price
$43.42
TNGX EPS estimates: the consensus estimate for Tango Therapeutics, Inc.'s current fiscal year is -$1.41 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TNGX EPS Estimates
- EPS estimate, current quarter
- $-0.34
- EPS estimate, next quarter
- $-0.36
- EPS estimate, current year
- $-1.41
- EPS estimate, next year
- $-1.64
- EPS growth, 3-year
- +10.90%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.87 |
| 2024 | $-1.19 |
| 2023 | $-1.08 |
| 2022 | $-1.23 |
| 2021 | $-0.94 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TNGX | $22.70 | +2.3% | 2.86M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tango Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW